These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31398679)

  • 1. Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis.
    Rojnic Kuzman M; Bosnjak Kuharic D; Ganoci L; Makaric P; Kekin I; Rossini Gajsak L; Prpic N; Bozina T; Bajic Z; Bozina N
    Eur Psychiatry; 2019 Sep; 61():88-96. PubMed ID: 31398679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime cannabis use and childhood trauma associated with CNR1 genetic variants increase the risk of psychosis: findings from the STREAM study.
    Loureiro CM; Corsi-Zuelli F; Fachim HA; Shuhama R; de Oliveira AM; Menezes PR; Dalton CF; Louzada-Junior P; Belangero SI; Coeli-Lacchini F; Reynolds GP; Lacchini R; Del-Ben CM
    Braz J Psychiatry; 2023; 45(3):226-235. PubMed ID: 36918037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.
    Ho BC; Wassink TH; Ziebell S; Andreasen NC
    Schizophr Res; 2011 May; 128(1-3):66-75. PubMed ID: 21420833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HSPA1B genotypes with psychopathology and neurocognition in patients with the first episode of psychosis: a longitudinal 18-month follow-up study.
    Bosnjak Kuharic D; Bozina N; Ganoci L; Makaric P; Kekin I; Prpic N; Bozina T; Rojnic Kuzman M
    Pharmacogenomics J; 2020 Oct; 20(5):638-646. PubMed ID: 32015459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of neurocognitive status in patients with the first-episode psychosis after 18 months of treatment-A prospective cohort study.
    Bosnjak Kuharic D; Makaric P; Kekin I; Rossini Gajsak L; Zivkovic M; Ostojic D; Silic A; Bajic Z; Lukacevic Lovrencic I; Beezhold J; Rojnic Kuzman M
    Psychiatry Res; 2021 Oct; 304():114131. PubMed ID: 34332430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls.
    Ferretjans R; de Souza RP; Panizzutti B; Ferrari P; Mantovani L; de Campos-Carli SM; Santos RR; Guimarães FC; Teixeira AL; Gama CS; Salgado JV
    Braz J Psychiatry; 2022; 44(1):26-34. PubMed ID: 34190825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.
    Onwuameze OE; Nam KW; Epping EA; Wassink TH; Ziebell S; Andreasen NC; Ho BC
    Psychol Med; 2013 Mar; 43(3):619-31. PubMed ID: 22850347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.
    Hou CL; Xiang YT; Wang ZL; Everall I; Tang Y; Yang C; Xu MZ; Correll CU; Jia FJ
    Schizophr Res; 2016 Jul; 174(1-3):71-76. PubMed ID: 27197904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms.
    Juhasz G; Chase D; Pegg E; Downey D; Toth ZG; Stones K; Platt H; Mekli K; Payton A; Elliott R; Anderson IM; Deakin JF
    Neuropsychopharmacology; 2009 Jul; 34(8):2019-27. PubMed ID: 19242408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with first-episode psychosis in northern Taiwan: neurocognitive performance and niacin response profile in comparison with schizophrenia patients of different familial loadings and relationship with clinical features.
    Yu SC; Hwang TJ; Liu CM; Chan HY; Kuo CJ; Yang TT; Wang JP; Liu CC; Hsieh MH; Lin YT; Chien YL; Kuo PH; Shih YW; Yu SL; Chen HY; Chen WJ
    BMC Psychiatry; 2024 Feb; 24(1):155. PubMed ID: 38389072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive development in first episode psychosis 5 years follow-up: associations between illness severity and cognitive course.
    Barder HE; Sundet K; Rund BR; Evensen J; Haahr U; Ten Velden Hegelstad W; Joa I; Johannessen JO; Langeveld H; Larsen TK; Melle I; Opjordsmoen S; Røssberg JI; Simonsen E; Vaglum P; McGlashan T; Friis S
    Schizophr Res; 2013 Sep; 149(1-3):63-9. PubMed ID: 23810121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A variant on promoter of the cannabinoid receptor 1 gene (CNR1) moderates the effect of valence on working memory.
    Fairfield B; Mammarella N; Franzago M; Di Domenico A; Stuppia L; Gatta V
    Memory; 2018 Feb; 26(2):260-268. PubMed ID: 28685667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of neuropsychological functioning and coping style on perceived stress in individuals with first-episode psychosis and healthy controls.
    Allott KA; Rapado-Castro M; Proffitt TM; Bendall S; Garner B; Butselaar F; Markulev C; Phassouliotis C; McGorry PD; Wood SJ; Cotton SM; Phillips LJ
    Psychiatry Res; 2015 Mar; 226(1):128-35. PubMed ID: 25618467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCF4 gene polymorphism and cognitive performance in patients with first episode psychosis.
    Albanna A; Choudhry Z; Harvey PO; Fathalli F; Cassidy C; Sengupta SM; Iyer SN; Rho A; Lepage M; Malla A; Joober R
    Schizophr Res; 2014 Jan; 152(1):124-9. PubMed ID: 24275585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Working memory performance in young adults is associated to the AATn polymorphism of the CNR1 gene.
    Ruiz-Contreras AE; Carrillo-Sánchez K; Gómez-López N; Vadillo-Ortega F; Hernández-Morales S; Carnevale-Cantoni A; Espejel-Núñez A; Méndez-Díaz M; Prospéro-García O
    Behav Brain Res; 2013 Jan; 236(1):62-66. PubMed ID: 22944513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women.
    Woo JH; Kim H; Kim JH; Kim JG
    Menopause; 2015 May; 22(5):512-9. PubMed ID: 25268406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms.
    Suárez-Pinilla P; Roiz-Santiañez R; Ortiz-García de la Foz V; Guest PC; Ayesa-Arriola R; Córdova-Palomera A; Tordesillas-Gutierrez D; Crespo-Facorro B
    Psychiatry Res; 2015 Aug; 233(2):112-9. PubMed ID: 26071625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.